Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.

被引：1
|
作者：
Krishnan, Tharani
Vasconcelos, Joao Paulo Solar
Titmuss, Emma
Topham, James Thomas
Schaeffer, David F.
Karsan, Aly
Lim, Howard J.
Ho, Cheryl
Gill, Sharlene
Kennecke, Hagen Fritz
Jonker, Derek J.
Chen, Eric Xueyu
Renouf, Daniel John
O'Callaghan, Christopher J.
Loree, Jonathan M.
机构：
[1] BC Canc Vancouver, Vancouver, BC, Canada
[2] BCCA, Genome Sci Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, BC Canc Vancouver, Vancouver, BC, Canada
[4] Providence Canc Inst, Portland, OR USA
[5] Ottawa Hosp, Canc Ctr, Ottawa, ON, Canada
[6] Univ Hlth Network, Toronto, ON, Canada
[7] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
3282-415-6705; 261-492-199-2823; 283-237-255; 130-231; 261-374; 261-566-148; 8; 4; 3; 3618; 3580; 2; 1; 38092-21872; 38092-33634; 38092-18438; 38092-18392;
D O I：
10.1200/JCO.2024.42.3_suppl.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：169 / 169
页数：1
相关论文
共 37 条
  • [21] Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data
    Hopkins, Ashley M.
    Van Dyk, Madele
    Rowland, Andrew
    Sorich, Michael J.
    PIGMENT CELL & MELANOMA RESEARCH, 2019, 32 (04) : 576 - 583
  • [22] PRODUCTION AND IMPLEMENTATION OF CLINICAL DATA STANDARDS IN REAL-WORLD SETTINGS FOR TIME-TO-EVENT ANALYSIS WITH MULTIPLE EVENTS AND CENSORING OUTCOMES ACROSS SUBGROUPS
    Hoag, J.
    Bhatt, R.
    Gilbert, G. E.
    Sen, G.
    VALUE IN HEALTH, 2020, 23 : S84 - S84
  • [23] Treatment patterns, indicators of receiving systemic treatment, and clinical outcomes in metastatic urothelial carcinoma: A retrospective analysis of real-world data in Germany.
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Guenther, Silke
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [24] Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies
    Ivashkin, Vladimir T.
    Maevskaya, Marina, V
    Shirokova, Elena N.
    Maev, Igor, V
    Samsonov, Alexey A.
    Sas, Evgeniy, I
    Palgova, Liudmila K.
    Starostin, Kirill
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (03) : 369 - 382
  • [25] Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies
    Vladimir T. Ivashkin
    Marina V. Maevskaya
    Elena N. Shirokova
    Igor V. Maev
    Alexey A. Samsonov
    Evgeniy I. Sas
    Liudmila K. Palgova
    Kirill Starostin
    Drugs - Real World Outcomes, 2021, 8 : 369 - 382
  • [26] Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study
    Zhang, Ling
    Hauske, Sibylle
    Ono, Yasuhisa
    Kyaw, Moe H.
    Steubl, Dominik
    Naito, Yusuke
    Kanasaki, Keizo
    BMJ OPEN, 2022, 12 (02):
  • [27] Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data
    Yang, Jingyan
    Liu, Rongzhe
    Granghaud, Anna
    Zaidi, Omer
    Stephens, Jennifer
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 665 - 674
  • [28] Projection of Health Outcomes Comparing LDV/SOF vs. SOF plus SMV - An Analysis Based on Clinical Trial vs. Real-World Data
    Park, Haesuk
    Ahmed, Aijaz
    Dieterich, Douglas T.
    Saab, Sammy
    Gordon, Stuart C.
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2015, 148 (04) : S970 - S970
  • [29] Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data
    Margaret von Mehren
    Michael C. Heinrich
    Hongliang Shi
    Sergio Iannazzo
    Raymond Mankoski
    Saša Dimitrijević
    Gerard Hoehn
    Silvia Chiroli
    Suzanne George
    BMC Cancer, 21
  • [30] Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data
    von Mehren, Margaret
    Heinrich, Michael C.
    Shi, Hongliang
    Iannazzo, Sergio
    Mankoski, Raymond
    Dimitrijevic, Sasa
    Hoehn, Gerard
    Chiroli, Silvia
    George, Suzanne
    BMC CANCER, 2021, 21 (01)
1234